Bristol-Myers Squibb Company (BMY) Financials

BMY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 86.5 billion 66.4 billion
Dec. 31, 2025 90.0 billion 71.5 billion
Sept. 30, 2025 96.9 billion 78.3 billion
June 30, 2025 94.7 billion 77.2 billion

BMY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 757.0 million 146.0 million
Dec. 31, 2025 1.6 billion 133.0 million
Sept. 30, 2025 6.0 billion 139.0 million
June 30, 2025 3.6 billion 137.0 million

BMY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 2.7 billion
Dec. 31, 2025 1.1 billion
Sept. 30, 2025 2.2 billion
June 30, 2025 1.3 billion

BMY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 10.5 billion 42.2 billion -
Dec. 31, 2025 10.7 billion 42.9 billion 2.0 billion
Sept. 30, 2025 16.5 billion 44.5 billion 2.1 billion
June 30, 2025 13.6 billion 44.5 billion 1.7 billion

BMY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 2.0 billion
Dec. 31, 2025 2.0 billion
Sept. 30, 2025 2.0 billion
June 30, 2025 2.0 billion

BMY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 347.0 million 2.6 billion 1.6 billion -
Dec. 31, 2025 370.0 million 2.6 billion 2.2 billion -
Sept. 30, 2025 320.0 million 2.5 billion 1.8 billion -
June 30, 2025 361.0 million 2.3 billion 1.7 billion -

BMY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 11.5 billion 3.4 billion
Dec. 31, 2025 12.5 billion 4.1 billion
Sept. 30, 2025 12.2 billion 3.4 billion
June 30, 2025 12.3 billion 4.2 billion

BMY Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BMY

List: Contenders

Price: $57.66

52 week price:
42.52
62.89

Dividend Yield: 4.43%

5-year range yield:
2.85%
5.88%

Forward Dividend Yield: 4.35%

Payout Ratio: -73.85%

Payout Ratio Range:
-1201.18%
4600.00%

Dividend Per Share: 2.52 USD

Earnings Per Share: 3.57 USD

P/E Ratio: 15.85

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 10.2 million

Ebitda: 946.0 million

Market Capitalization: 115.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 55

DGR3: 5.26%

DGR5: 6.95%

DGR10: 5.32%

DGR20: 4.05%

Links: